Hochtief Retreats as ACS Denies Takeover Bid

ACS Filing Deflates the Takeover Premium

Hochtief was trading at €349.60 as of 9 November 2026 at 09:34 UTC, down -5.15% against the previous close — the latest move in what has become a volatile two-session sequence driven by conflicting signals from its Spanish parent.

The selloff followed a mandatory filing ACS submitted to Spain's market regulator, the CNMV, on 7 November 2026, in which the company stated categorically that it had considered neither a tender offer for Hochtief shares nor a sale of Turner shares. The denial was reported by Bloomberg and dpa-AFX. Notably, the CNMV statement did not directly address the merger option that Bloomberg's original report had included, leaving one element of the story unresolved.

The filing was a direct response to a Bloomberg report published on 6 November 2026, which said ACS — Hochtief's majority owner with more than 75% of the company — was reviewing strategic options including a potential buyout of minority shareholders, a merger of the two groups, or a New York listing of Hochtief's U.S. construction arm, Turner Construction. That report sent Hochtief shares jumping about 9% in Frankfurt on 6 November, as investors priced in the possibility of a transaction at a premium. The move on 9 November is the second sharp swing this month on ACS-related news.

The current decline coincided with the cooling of that takeover premium. With ACS having denied the two most concrete options — a tender offer and a Turner sale — the drop came despite Hochtief reporting strong third-quarter results, with operational net profit rising 40% and the order book reaching a record high of almost €90 billion, up 29% year-on-year. Sales grew 14% year-on-year in the first nine months of 2026, reaching over €32 billion, and operating cash flow increased by over €620 million year-on-year.

A Stock Already Under Six-Month Pressure

The session's decline lands on a share that has been retreating for months. Over the past six months, Hochtief has shed -35.55%, with the stock well below its six-month high of €553.10.

The one-month range tells a similar story of compression and volatility: a low of €330.40 and a high of €395.20, with the current price sitting in the lower half of that band even after last week's deal-driven bounce. The fundamental picture — record order book, accelerating sales, rising cash flow — has not been enough to arrest the broader decline, and the ACS denial has now removed the near-term catalyst that briefly interrupted it.

Merger Option Still Open, Outcome Uncertain

The CNMV filing's silence on the merger scenario is the open question the market is now pricing around. ACS denied a tender offer and a Turner sale, but did not address whether a full merger of the two groups remains under consideration — the gap Bloomberg's report originally flagged.

No next scheduled corporate event has been confirmed in the available material. Until ACS clarifies its position on the merger option, or Hochtief provides further guidance, the shares are likely to remain sensitive to any further statements from either company or their advisers.